THRIVENT FINANCIAL FOR LUTHERANS - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 204 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 16.41 and the average weighting 0.1%.

Quarter-by-quarter ownership
THRIVENT FINANCIAL FOR LUTHERANS ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$2,940
-42.0%
63,930
-27.5%
0.01%
-41.7%
Q2 2023$5,065
+261.5%
88,131
+135.9%
0.01%
+300.0%
Q1 2023$1,401
+29.2%
37,359
-3.4%
0.00%0.0%
Q4 2022$1,084
-99.9%
38,669
-2.2%
0.00%0.0%
Q3 2022$1,111,000
-13.5%
39,521
+7.0%
0.00%0.0%
Q2 2022$1,285,000
+19.3%
36,940
+23.2%
0.00%
+50.0%
Q1 2022$1,077,000
+54.3%
29,994
+0.0%
0.00%
+100.0%
Q4 2021$698,000
+22.9%
29,984
+0.3%
0.00%0.0%
Q3 2021$568,000
-6.0%
29,895
-0.3%
0.00%0.0%
Q2 2021$604,000
+9.8%
29,985
-0.2%
0.00%0.0%
Q1 2021$550,000
-9.7%
30,048
-0.8%
0.00%0.0%
Q4 2020$609,000
+7.2%
30,277
-0.1%
0.00%
-50.0%
Q3 2020$568,000
-10.4%
30,319
+7.4%
0.00%0.0%
Q2 2020$634,000
+48.8%
28,228
-1.7%
0.00%0.0%
Q1 2020$426,000
-19.0%
28,717
+5.3%
0.00%
+100.0%
Q4 2019$526,000
-3.1%
27,283
-0.4%
0.00%
-50.0%
Q3 2019$543,000
-6.7%
27,392
-0.6%
0.00%0.0%
Q2 2019$582,000
+7.8%
27,567
+4.3%
0.00%0.0%
Q1 2019$540,000
+11.1%
26,426
+8.3%
0.00%0.0%
Q4 2018$486,000
+0.8%
24,399
-2.6%
0.00%0.0%
Q3 2018$482,000
+28.2%
25,062
+1.8%
0.00%
+100.0%
Q2 2018$376,000
-12.4%
24,622
+7.7%
0.00%0.0%
Q1 2018$429,0000.0%22,872
+2.6%
0.00%0.0%
Q4 2017$429,000
+9.7%
22,300
+2.0%
0.00%0.0%
Q3 2017$391,000
+1.3%
21,860
+1.2%
0.00%
-50.0%
Q2 2017$386,000
+32.2%
21,610
+7.2%
0.00%
+100.0%
Q1 2017$292,000
-18.4%
20,150
+3.7%
0.00%
-50.0%
Q4 2016$358,000
-0.8%
19,440
+2.1%
0.00%0.0%
Q3 2016$361,00019,0400.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q1 2022
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$4,884,3754.79%
SHAKER INVESTMENTS LLC/OH 82,253$3,084,4881.72%
Mesirow Institutional Investment Management, Inc. 325,669$12,212,5881.33%
Portolan Capital Management 340,593$12,772,2381.22%
OBERWEIS ASSET MANAGEMENT INC/ 178,200$6,682,5001.04%
Granite Investment Partners, LLC 536,821$20,130,7880.84%
Capital Impact Advisors, LLC 15,304$573,9000.70%
Hillsdale Investment Management Inc. 155,038$5,813,9260.50%
GLOBEFLEX CAPITAL L P 89,192$3,344,7000.41%
Jackson Creek Investment Advisors LLC 25,877$9700.41%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders